|Bid||0.00 x 800|
|Ask||0.00 x 3000|
|Day's Range||46.30 - 50.42|
|52 Week Range||18.76 - 54.96|
|Beta (5Y Monthly)||1.34|
|PE Ratio (TTM)||45.02|
|Earnings Date||Feb 25, 2021|
|Forward Dividend & Yield||0.44 (0.87%)|
|Ex-Dividend Date||Mar 08, 2021|
|1y Target Est||54.00|
LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) is about to trade ex-dividend in the next four days. You can purchase shares...
Image source: The Motley Fool. LeMaitre Vascular inc (NASDAQ: LMAT)Q4 2020 Earnings CallFeb 25, 2021, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to the LeMaitre Vascular Q4 2020 Financial Results Conference Call.
Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 47.83% over the past year to $0.34, which beat the estimate of $0.29. Revenue of $37,548,000 up by 24.45% from the same period last year, which beat the estimate of $35,580,000. Looking Ahead LeMaitre Vascular hasn't issued any earnings guidance for the time being. LeMaitre Vascular hasn't issued any revenue guidance for the time being. Conference Call Details Date: Feb 25, 2021 View more earnings on LMAT Time: 05:00 PM ET Webcast URL: https://edge.media-server.com/mmc/p/cmk74ikf Recent Stock Performance 52-week high: $50.53 52-week low: $18.76 Price action over last quarter: Up 43.01% Company Overview LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States. Sales in Germany also contribute a significant proportion of total revenue. See more from BenzingaClick here for options trades from BenzingaEarnings Preview for LeMaitre VascularBenzinga's Top Ratings Upgrades, Downgrades For February 12, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.